ClinicalTrials.Veeva

Menu

Attention Training Technique in Treatment of Anxiety and Depression in Coronary Heart Disease Patients

V

Vestre Viken Hospital Trust

Status

Enrolling

Conditions

Coronary Artery Disease
Depression, Anxiety

Treatments

Behavioral: Attention Training Technique

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Anxiety and depression are associated with work disability, lower participation rate in cardiac rehabilitation and unfavourable life style changes following a coronary heart disease (CHD) event. The prevalence of clinically significant symptoms of depression and anxiety in CHD patients has been estimated to 30-50%. Furthermore, depression and anxiety are associated with a significant increased risk of subsequent major adverse cardiovascular events and mortality in CHD patients. Psychological interventions for anxiety and depression in CHD patients have demonstrated small and uncertain effects of symptoms, and no effect on cardiovascular outcomes. Therefore, testing the effectiveness of specific psychological interventions that may affect central mechanisms for cardiovascular outcomes, has been requested. The Attention training (ATT) Study is a randomized controlled trial comparing group-attention training to wait-list control in 64 patients who experience significant anxiety and depression after a CHD event. It will also be explored whether reduction in psychological symptoms is correlated with changes in biological markers with a potential link to cardiovascular outcomes.

Enrollment

64 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Established coronary heart disease as main somatic disease
  • >=8 on either HADS-anxiety or depression subscale
  • Age 18 - 65 years
  • The ability to understand and speak Norwegian language,
  • Willingness and ability to give informed consent.

Exclusion criteria

  • Current or past neurological illness
  • Traumatic brain injury
  • Current alcohol and/or substance dependency disorders
  • Psychotic disorders
  • Bipolar disorders
  • Developmental disorders
  • Mental retardation
  • Cognitive impairment which precludes informed consent/ability to participate
  • Acute suicidality
  • Life-expectancy less than 12 months
  • Concurrent psychological intervention for emotional distress
  • Antidepressant or anxiolytic medication initiated during previous 8 weeks

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

64 participants in 2 patient groups

Attention Training Techniqe
Experimental group
Description:
The treatment manual will consist of up to six weekly group sessions with 45-90 minutes duration.
Treatment:
Behavioral: Attention Training Technique
Wait-list control
No Intervention group
Description:
The wait-list control condition will not receive any psychological intervention during the six weeks waiting period. Subsequently, this group will also receive the intervention if the study entry criteria is still fulfilled

Trial contacts and locations

2

Loading...

Central trial contact

Toril Dammen, MD,PhD; John Munkhaugen, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems